We used CRISPR-Cas9 to perform loss-of-function experiments of the reader YTHDF3 in two GC cell lines, AGS and SNU638, which presented different basal expression levels (strategy depicted in Supplementary Fig. 2A). Here, YTHDF3 is linked to gastric cancer.